Burt Angrist

2.9k total citations
61 papers, 2.2k citations indexed

About

Burt Angrist is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Burt Angrist has authored 61 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Psychiatry and Mental health, 20 papers in Cellular and Molecular Neuroscience and 10 papers in Neurology. Recurrent topics in Burt Angrist's work include Schizophrenia research and treatment (26 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Electroconvulsive Therapy Studies (9 papers). Burt Angrist is often cited by papers focused on Schizophrenia research and treatment (26 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Electroconvulsive Therapy Studies (9 papers). Burt Angrist collaborates with scholars based in United States, Canada and United Kingdom. Burt Angrist's co-authors include John Rotrosen, Samuel Gershon, Lenard A. Adler, Eric D. Peselow, June Corwin, Thomas B. Cooper, S Gershon, Daniël P. van Kammen, Michael Sanfilipo and Stewart Reiter and has published in prestigious journals such as Nature, American Journal of Psychiatry and Trends in Neurosciences.

In The Last Decade

Burt Angrist

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burt Angrist United States 23 1.2k 765 464 324 309 61 2.2k
Frits‐Axel Wiesel Sweden 27 1.1k 1.0× 1.1k 1.4× 297 0.6× 267 0.8× 551 1.8× 65 2.5k
Celeste A. Johns United States 21 1.5k 1.3× 433 0.6× 387 0.8× 254 0.8× 252 0.8× 34 2.5k
David L. Garver United States 28 988 0.8× 591 0.8× 322 0.7× 156 0.5× 430 1.4× 82 2.3k
F.‐A. Wiesel Sweden 28 830 0.7× 764 1.0× 377 0.8× 196 0.6× 375 1.2× 46 2.0k
Hugo A. Jørgensen Norway 25 828 0.7× 492 0.6× 385 0.8× 248 0.8× 263 0.9× 83 1.9k
Henrik Lublin Denmark 25 1.3k 1.1× 392 0.5× 438 0.9× 166 0.5× 212 0.7× 59 2.0k
Burton Angrist United States 34 1.4k 1.2× 1.7k 2.2× 787 1.7× 316 1.0× 594 1.9× 62 3.2k
Joseph F. Lipinski United States 25 874 0.7× 337 0.4× 241 0.5× 238 0.7× 233 0.8× 43 1.7k
Richard C. Meibach United States 24 1.1k 0.9× 1.5k 1.9× 1.3k 2.7× 239 0.7× 400 1.3× 36 3.2k
Henrik Nybäck Sweden 25 592 0.5× 1.0k 1.3× 366 0.8× 176 0.5× 713 2.3× 53 2.1k

Countries citing papers authored by Burt Angrist

Since Specialization
Citations

This map shows the geographic impact of Burt Angrist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burt Angrist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burt Angrist more than expected).

Fields of papers citing papers by Burt Angrist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burt Angrist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burt Angrist. The network helps show where Burt Angrist may publish in the future.

Co-authorship network of co-authors of Burt Angrist

This figure shows the co-authorship network connecting the top 25 collaborators of Burt Angrist. A scholar is included among the top collaborators of Burt Angrist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burt Angrist. Burt Angrist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reid, Malcolm S., Burt Angrist, Sherryl Baker, et al.. (2005). A placebo‐controlled screening trial of celecoxib for the treatment of cocaine dependence. Addiction. 100(s1). 32–42. 12 indexed citations
2.
Duncan, Erica, Sándor Miklós Szilágyi, Marion Schwartz, et al.. (2004). Effects of d-cycloserine on negative symptoms in schizophrenia. Schizophrenia Research. 71(2-3). 239–248. 74 indexed citations
3.
Duncan, Erica, Sándor Miklós Szilágyi, Toby R. Efferen, et al.. (2003). Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology. 167(1). 63–71. 56 indexed citations
4.
Alpert, Murray & Burt Angrist. (2003). The ketamine model for schizophrenia. Behavioral and Brain Sciences. 26(1). 82–83. 4 indexed citations
5.
Angrist, Burt, John Rotrosen, & S Gershon. (2001). Commentary on: "Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia." Psychopharmacology (1980) 72:17-19. Psychopharmacology. 158(3). 219–221. 4 indexed citations
6.
Duncan, Erica, et al.. (2000). Akathisia and Exacerbation of Psychopathology: A Preliminary Report. Clinical Neuropharmacology. 23(3). 169–173. 20 indexed citations
7.
Volkow, Nora D., Joanna S. Fowler, Jean Logan, et al.. (1997). Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. American Journal of Psychiatry. 154(1). 50–55. 145 indexed citations
8.
Adler, Lenard A., et al.. (1996). Nefazodone and akathisia. Biological Psychiatry. 40(8). 798–799. 12 indexed citations
9.
Sanfilipo, Michael, Grant N. Ko, Burt Angrist, et al.. (1993). Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biological Psychiatry. 34(9). 641–649. 114 indexed citations
10.
Adler, Lenard A., Burt Angrist, & John Rotrosen. (1991). Efficacy of betaxolol in neuroleptic-induced akathisia. Psychiatry Research. 39(2). 193–198. 3 indexed citations
11.
Bartlett, Elsa J., F Barouche, Jonathan D. Brodie, et al.. (1991). Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia. Psychiatry Research Neuroimaging. 40(1). 11–19. 32 indexed citations
12.
Brody, David L., et al.. (1990). Effects of Buspirone in Seven Schizophrenic Subjects. Journal of Clinical Psychopharmacology. 10(1). 68–68. 30 indexed citations
13.
Adler, Lenard A., Burt Angrist, & John Rotrosen. (1990). Metoprolol versus propranolol. Biological Psychiatry. 27(6). 673–675. 10 indexed citations
14.
Adler, Lenard A., et al.. (1989). Effects of a specific beta2-receptor blocker in neuroleptic-induced akathisia. Psychiatry Research. 27(1). 1–4. 14 indexed citations
15.
Adler, Lenard A., Burt Angrist, Stewart Reiter, & John Rotrosen. (1989). Neuroleptic-induced akathisia: a review. Psychopharmacology. 97(1). 1–11. 99 indexed citations
16.
Angrist, Burt, et al.. (1988). Preliminary studies of clonidine in psychotic patients. Journal of Neural Transmission. 71(2). 115–121. 3 indexed citations
17.
Angrist, Burt, et al.. (1987). Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biological Psychiatry. 22(11). 1357–1368. 144 indexed citations
18.
Rotrosen, John, et al.. (1978). Neuroendocrine studies with dopamine agonists in schizophrenia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(1). 14–7. 22 indexed citations
19.
Angrist, Burt & Samuel Gershon. (1977). Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16. 677–80. 21 indexed citations
20.
Angrist, Burt, John Rotrosen, Melyssa Aronson, & Samuel Gershon. (1976). A morphanthridine derivative in schizophrenic patients -- lack of extrapyramidal symptoms.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(1). 94–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frits‐Axel Wiesel Breakdown of academic impact, for papers by Celeste A. Johns Breakdown of academic impact, for papers by David L. Garver Breakdown of academic impact, for papers by F.‐A. Wiesel Breakdown of academic impact, for papers by Hugo A. Jørgensen Breakdown of academic impact, for papers by Henrik Lublin Breakdown of academic impact, for papers by Burton Angrist Breakdown of academic impact, for papers by Joseph F. Lipinski Breakdown of academic impact, for papers by Richard C. Meibach Breakdown of academic impact, for papers by Henrik Nybäck
Rankless by CCL
2026